2 predictions for Novo Nordisk in 2026

Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...

COMMENTARY: The real story behind Trump’s GLP-1 price cut: Markets still rule

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV

In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of ...

WHO releases new guidance for GLP-1 weight loss drugs: What to know

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...
Medical Dialogues

Novo Nordisk Gets CDSCO Panel Nod to Update Wegovy Label With New Safety, Pharmacodynamics Data

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...